Skip to main content
. 2021 Sep 16;16(1):236–258. doi: 10.1111/jnp.12262

Table 2.

Prevalence of neuropsychiatric symptoms by patient group

AD (n = 28) LE (n = 30) PD (n = 48) SCI (n = 28)
Impaired a 25/28 (89.29%) 10/27 (37.04%) 11/45 (24.44%) 5/28 (17.86%)
Apathetic b 22/28 (78.57%) 14/29 (48.28%) 16/46 (34.78%) 8/25 (32%)
Depressed d 4/28 (14.29%) 17/29 (58.62%) 13/47 (27.66%) 15/28 (53.57%)
Anhedonic d 2/28 (7.14%) 6/30 (20%) 2/47 (4.26%) 6/28 (21.43%)
Apathetic & Impaired 19/28 (67.86%) 6/26 (23.08%) 8/41 (19.51%) 2/25 (8%)
Apathetic & Depressed 3/28 (10.71%) 8/26 (30.77%) 8/41 (19.51%) 4/25 (16%)
Apathetic & Anhedonic 2/28 (7.14%) 4/26 (15.38%) 1/41 (2.44%) 1/25 (4%)

AD, Alzheimer's disease; LE, Limbic encephalitis; PD, Parkinson's disease; SCI, Subjective cognitive impairment.

a

Cognitive impairment indicated by a score smaller than 88 on the ACE. Missing data: 3 LE, 3 PD.

b

Apathy, indicated either by a score greater than 1.91 on the AMI (moderate apathy) or by a score greater than −16 on the LARS‐i. Missing observations: 1 LE, 2 PD, 3 SCI.

c

Depression, indicated either by a score greater than 17 (moderate depression) or by a score greater than 5 on the GDS. Missing data: 1 LE, 1 PD.

d

Anhedonia, indicated by a score greater than 2 on the SHAPS. Missing data: 1 PD.